Illumina 測序試劑盒 RS-122-2002
Illumina/TruSeq RNA Library Preparation Kit v2, Set B (48 samples, 12 indexes)/RS-122-2002/1 Ea

產品編號： RS-122-2002
美  元  價： $3591.00
會  員  價： 待定
品       牌： Illumina
產       地： 美國
公       司： Illumina, Inc.
產品分類： 分子類>二代測序>DNA文庫制備試劑盒
公司分類： Library Preparation Kits

Illumina公司創(chuàng)立于1998年4月，是遺傳變異和生物學功能分析領域的優(yōu)秀的產品、技術和服務供應商。通過幫助客戶加快實現(xiàn)生物信息的采集、分析和應用，來改善人類健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

Product Highlights:

Generate mRNA-focused sequencing libraries from total RNA, with enhanced multiplex capABIlity and a simplified workflow with master-mixed reagents.

Kits feature 24 unique indexes, delivering enhanced multiplex performance for processing large numbers of samples (including up to 384 RNA-Seq samples on a single HiSeq 2500 System run).

Master-mixed reagents eliminate the majority of pipetting steps and reduce the amount of clean-up, as compared to previous methods, minimizing hands-on time. This results in economical, high-throughput RNA sequencing studies achieved with the easiest-to-use sample preparation workflow offered by any NGS platform.

Find an up-to-date list of high-throughput automation vendors with robotic systems compatIBLe with this library preparation kit

Specifications:

上海易匯生物科技有限公司于17年正式銷售Illumina公司基因芯片、二代測序NGS測序儀及相關測序試劑盒等產品

咨詢illumina MiSeq測序試劑盒等產品歡迎您致電 上海易匯生物科技有限公司：1850 1609 238張經理

Illumina公司，致力于新一代測序和芯片技術的生產與開發(fā)，提供的產品與應用資訊。Illumina公司創(chuàng)立于1998年4月，是遺傳變異和生物學功能分析領域的優(yōu)秀的產品、技術和服務供應商。通過幫助客戶加快實現(xiàn)生物信息的采集、分析和應用，來改善人類健康。

As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go

While the rate of progress is accelerating exponentially, we are only beginning to understand the clinical significance of the genome. What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination

Today we are a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

We now have the ability to sequence at an unprecedented scale. Collectively, this will give us a much deeper understanding of genetics than ever before. We will begin to truly unlock the power of the genome. These advances will trigger a fundamental shift in healthcare and beyond. Medicine will continue to become more preventive and more precise. We will be healthier, longer. We have only just begun.

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics

Illumina 測序試劑盒 RS-122-2002